What we have been doing.

Lab Venture Challenge finalist

Venture Partners at CU Boulder selected Regelife as a 2026 Lab Venture Challenge finalist in the bioscience track, for AI designed biomaterials for regenerative medicine. Finalists pitch to a panel of judges and a live audience for a share of more than $1 million in non dilutive grants. Mark Ma pitches on October 22 at the Dairy Arts Center in Boulder.

Lab Venture Challenge

Japan US ALS Forum, Tokyo

Regelife presented its ALS cell therapy research at the Japan US ALS Forum, hosted by Tokyo Dome with Keio University's Regenerative Medicine Research Center and ALS Network. Mark Ma spoke on rebuilding neural connections in ALS alongside Professor Hideyuki Okano and ALS Network CEO Sheri Strahl, to an audience of about 130 people including patients, families and researchers.

Event reportJapanese